Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GLYC GlycoMimetics Inc

-0.0079 (-2.92%)
Jun 15 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 552,371
Bid Price 0.0652
Ask Price 0.2811
News -
Day High 0.2807


52 Week Range


Day Low 0.26
Company Name Stock Ticker Symbol Market Type
GlycoMimetics Inc GLYC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0079 -2.92% 0.2626 00:00:04
Open Price Low Price High Price Close Price Prev Close
0.2719 0.26 0.2807 0.263 0.2705
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,293 552,371 $ 0.2671736 $ 147,579 - 0.251 - 3.5299
Last Trade Time Type Quantity Stock Price Currency
18:33:56 25 $ 0.2629 USD

GlycoMimetics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
16.74M 64.39M - 10k -36.9M -0.57 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

GlycoMimetics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No GLYC Message Board. Create One! See More Posts on GLYC Message Board See More Message Board Posts

Historical GLYC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.26340.290.2510.263571536,761-0.0008-0.30%
1 Month0.2830.310.2510.27899991,061,634-0.0204-7.21%
3 Months2.903.180.2510.69613921,841,078-2.64-90.94%
6 Months1.903.52990.2511.091,045,506-1.64-86.18%
1 Year1.783.52990.2511.14585,062-1.52-85.25%
3 Years2.784.160.2511.68517,810-2.52-90.55%
5 Years11.3213.410.2512.61540,475-11.06-97.68%

GlycoMimetics Description

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.

Your Recent History

Delayed Upgrade Clock